Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Thrombosis, bleeding, and progression in JAK2 V617F clonal hematopoiesis

Rathnam Venkat, Robert Redd, Gabriela Hobbs, Chi-Joan How

Blood (2025) 146 (Supplement 1): 3168.

https://doi.org/10.1182/blood-2025-3168

Published: 2025

Journal Articles

A phase I study of the combination of ruxolitinib and the ERK1/2 inhibitor ulixertinib in previously treated myelofibrosis patients.

Chi-Joan How, Gabriela Hobbs, Aaron Gerds, Andriy Derkach, Emily Burton, Aurora Duran, Katherine Kan, Michael Mauro, Brian Chernak, Tamanna Haque, Raajit Rampal

Blood (2025) 146 (Supplement 1): 5606.

https://doi.org/10.1182/blood-2025-5606

Published: 2025

Journal Articles

Decreased serum total cholesterol is associated with worse outcomes among patients with myeloproliferative neoplasms

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Michelle Lee, Chi-Joan How, Max Petersen, Patrycja Dubielecka, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 2020.

https://doi.org/10.1182/blood-2025-2020

Published: 2025

Journal Articles

Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients

Blood (2025) 146 (Supplement 1): 1026.

https://doi.org/10.1182/blood-2025-1026

Published: 2025

Journal Articles

Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia

Blood (2025) 146 (Supplement 1): 1024.

https://doi.org/10.1182/blood-2025-1024

Published: 2025

Journal Articles

Retrospective real-world analysis of ropeginterferon ALFA-2B use in patients with polycythemia vera and essential thrombocythemia: Practice patterns, tolerance, and outcomes

Katherine Feder, Jessica Freydman, Yue Ren, Shruti Gajjar, Victor You, David Sirignano, Svitlana Tyekucheva, Andrew Brunner, Jean M. Connors, Daniel Deangelo, Amir Fathi, Jacqueline Garcia, Chi-Joan How, Marlise Luskin, Richard Stone, Virginia Volpe, Michelle Lee, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 7338.

https://doi.org/10.1182/blood-2025-7338

Published: 2025

Journal Articles

Ruxolitinib and cardiovascular outcomes among patients with myelofibrosis

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 3796.

https://doi.org/10.1182/blood-2025-3796

Published: 2025

Journal Articles

Examining diet quality and patient-reported outcomes in myeloproliferative neoplasms: Results from a cross-sectional observational study

Chi-Joan How, Cami Christopher, Brunhilda Nkengfack, Richard Newcomb, Bridget Coffey, Victor You, Gabriela Hobbs, Hermioni Amonoo, Areej El-Jawahri, Christina Dieli-Conwright

Blood (2025) 146 (Supplement 1): 6387.

https://doi.org/10.1182/blood-2025-6387

Published: 2025

Journal Articles

Pulmonary hypertension on right heart catheterization is associated with worse progression-free survival in patients with myeloproliferative neoplasms

Orly Leiva, Olivia Liu, Victor You, Steven Soo, Justin Kahla, Yasmeen Murtaza, Andrew Palmer, Anand Patel, Olatoyosi Odenike, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5583.

https://doi.org/10.1182/blood-2025-5583

Published: 2025

Journal Articles

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Max Petersen, Patrycja Dubielecka, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5571.

https://doi.org/10.1182/blood-2025-5571

Published: 2025

Journal Articles

Cellular and Serologic Responses to Influenza Vaccination in Myeloproliferative Neoplasm Patients

Chi-Joan How, Stella Nam, Charlene Kok, Sonia Mukherjee, Petra Bachanová, Patrick Reeves, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 6563.

https://doi.org/10.1182/blood-2024-210631

Published: 2024

Journal Articles

Trial-in-Progress: A Phase 2 Study of Ruxolitinib in Low-Risk Essential Thrombocythemia and Polycythemia Vera Patients with High Symptom Burden

Chi-Joan How, Yiwen Liu, Kathleen Gallagher, Emma K Logan, Ann Mullally, Donna S. Neuberg, Thomas Reardon, Alyssa Watson, Daniel J. DeAngelo, Rushad Patell, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 6644.

https://doi.org/10.1182/blood-2024-194126

Published: 2024

Journal Articles

Incidence, Risk Factors, and Prognostic Implications of Heart Failure Hospitalizations Among Patients with Myeloproliferative Neoplasms

Orly Leiva, Steven Soo, Nathaniel Smilowitz, Harmony Reynolds, Binita Shah, Samuel Bernard, Michelle Hyunju Lee, Chi-Joan How, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 3188.

https://doi.org/10.1182/blood-2024-207586

Published: 2024

Journal Articles

Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms and Predictors of Hematologic Progression

Orly Leiva, Steven Soo, Nathaniel Smilowitz, Harmony Reynolds, Binita Shah, Samuel Bernard, Michelle Hyunju Lee, Chi-Joan How, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 246.

https://doi.org/10.1182/blood-2024-199120

Published: 2024

Journal Articles

Anticoagulation Management of Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Global Abdominal/Splanchnic Thrombosis Retrospective Observational Study in 486 MPN Patients (GASTRO-MPN)

Blood (2024) 144 (Supplement 1): 16.

https://doi.org/10.1182/blood-2024-199107

Published: 2024

Journal Articles

Factors Associated with Quality of Life Impairments in Patients with Myeloproliferative Neoplasms: Looking Beyond Symptom Burden

Chi-Joan How, Bridget Coffey, Christina M. Dieli-Conwright, Gabriela S. Hobbs, Hermioni L Amonoo, Areej El-Jawahri, Richard Newcomb

Blood (2024) 144 (Supplement 1): 3811.

https://doi.org/10.1182/blood-2024-194829

Published: 2024

Journal Articles

Myelofibrosis Is Associated with Poor Cardiovascular Outcomes after Heart Failure Hospitalization

Orly Leiva, Jose Alvarez-Cardona, Andrew M. Brunner, Chi-Joan How, Gabriela S. Hobbs

Blood (2023) 142 (Supplement 1): 3203.

https://doi.org/10.1182/blood-2023-173589

Published: 2023

Journal Articles

Real-World Experience of Ropeginterferon in Myeloproliferative Neoplasm Patients

Chi-Joan How, Gabriela S. Hobbs

Blood (2022) 140 (Supplement 1): 12284–12285.

https://doi.org/10.1182/blood-2022-157076

Published: 2022

Journal Articles

Trends in All-Cause and Cardiovascular Mortality Among Patients with Myeloproliferative Neoplasms: A Surveillance, Epidemiology, and End Results Database Analysis

Orly Leiva, Chi-Joan How, Andrew M. Brunner, Gabriela S. Hobbs

Blood (2022) 140 (Supplement 1): 6808–6809.

https://doi.org/10.1182/blood-2022-170607

Published: 2022

Journal Articles

High Incidence of Bleeding Found with Direct Oral Anticoagulant Use in Myeloproliferative Neoplasm Patients

Chi-Joan How, Charlotte McIlwaine Story, Siyang Ren, Donna S. Neuberg, Rachel P. Rosovsky, Gabriela Hobbs, Jean M. Connors

Blood (2021) 138 (Supplement 1): 3632.

https://doi.org/10.1182/blood-2021-148941

Published: 2021

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Thrombosis, bleeding, and progression in JAK2 V617F clonal hematopoiesis

A phase I study of the combination of ruxolitinib and the ERK1/2 inhibitor ulixertinib in previously treated myelofibrosis patients.

Decreased serum total cholesterol is associated with worse outcomes among patients with myeloproliferative neoplasms

Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients

Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia

Retrospective real-world analysis of ropeginterferon ALFA-2B use in patients with polycythemia vera and essential thrombocythemia: Practice patterns, tolerance, and outcomes

Ruxolitinib and cardiovascular outcomes among patients with myelofibrosis

Examining diet quality and patient-reported outcomes in myeloproliferative neoplasms: Results from a cross-sectional observational study

Pulmonary hypertension on right heart catheterization is associated with worse progression-free survival in patients with myeloproliferative neoplasms

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms

Cellular and Serologic Responses to Influenza Vaccination in Myeloproliferative Neoplasm Patients

Trial-in-Progress: A Phase 2 Study of Ruxolitinib in Low-Risk Essential Thrombocythemia and Polycythemia Vera Patients with High Symptom Burden

Incidence, Risk Factors, and Prognostic Implications of Heart Failure Hospitalizations Among Patients with Myeloproliferative Neoplasms

Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms and Predictors of Hematologic Progression

Anticoagulation Management of Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Global Abdominal/Splanchnic Thrombosis Retrospective Observational Study in 486 MPN Patients (GASTRO-MPN)

Factors Associated with Quality of Life Impairments in Patients with Myeloproliferative Neoplasms: Looking Beyond Symptom Burden

Myelofibrosis Is Associated with Poor Cardiovascular Outcomes after Heart Failure Hospitalization

Real-World Experience of Ropeginterferon in Myeloproliferative Neoplasm Patients

Trends in All-Cause and Cardiovascular Mortality Among Patients with Myeloproliferative Neoplasms: A Surveillance, Epidemiology, and End Results Database Analysis

High Incidence of Bleeding Found with Direct Oral Anticoagulant Use in Myeloproliferative Neoplasm Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only